Next Article in Journal
Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis—A Randomized Placebo Controlled Clinical Trial
Previous Article in Journal
7-Acetoxyhorminone from Salvia multicaulis Vahl. as Promising Inhibitor of 3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase
Previous Article in Special Issue
Bezafibrate Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer’s Disease
 
 
Case Report

Article Versions Notes

Pharmaceuticals 2022, 15(2), 199; https://doi.org/10.3390/ph15020199
Action Date Notes Link
article pdf uploaded. 4 February 2022 13:28 CET Version of Record https://www.mdpi.com/1424-8247/15/2/199/pdf-vor
article xml file uploaded 14 February 2022 10:33 CET Original file -
article xml uploaded. 14 February 2022 10:33 CET Update https://www.mdpi.com/1424-8247/15/2/199/xml
article pdf uploaded. 14 February 2022 10:33 CET Updated version of record https://www.mdpi.com/1424-8247/15/2/199/pdf
article html file updated 14 February 2022 10:34 CET Original file -
article html file updated 31 July 2022 10:30 CEST Update https://www.mdpi.com/1424-8247/15/2/199/html
Back to TopTop